- Home
- CRDF vs CBFV Comparison
CRDF vs CBFV Comparison
Compare CRDF & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- CBFV
- Stock Information
- Founded
- CRDF 1999
- CBFV 1901
- Country
- CRDF United States
- CBFV United States
- Employees
- CRDF N/A
- CBFV N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- CBFV Major Banks
- Sector
- CRDF Health Care
- CBFV Finance
- Exchange
- CRDF Nasdaq
- CBFV Nasdaq
- Market Cap
- CRDF 152.3M
- CBFV 153.2M
- IPO Year
- CRDF N/A
- CBFV N/A
- Fundamental
- Price
- CRDF $2.15
- CBFV $33.83
- Analyst Decision
- CRDF Strong Buy
- CBFV Buy
- Analyst Count
- CRDF 4
- CBFV 2
- Target Price
- CRDF $10.63
- CBFV $36.00
- AVG Volume (30 Days)
- CRDF 723.0K
- CBFV 6.2K
- Earning Date
- CRDF 11-06-2025
- CBFV 10-23-2025
- Dividend Yield
- CRDF N/A
- CBFV 3.06%
- EPS Growth
- CRDF N/A
- CBFV N/A
- EPS
- CRDF N/A
- CBFV 0.51
- Revenue
- CRDF $501,000.00
- CBFV $39,329,000.00
- Revenue This Year
- CRDF N/A
- CBFV $10.71
- Revenue Next Year
- CRDF N/A
- CBFV $12.52
- P/E Ratio
- CRDF N/A
- CBFV $66.80
- Revenue Growth
- CRDF N/A
- CBFV N/A
- 52 Week Low
- CRDF $1.90
- CBFV $26.01
- 52 Week High
- CRDF $5.64
- CBFV $34.50
- Technical
- Relative Strength Index (RSI)
- CRDF 43.50
- CBFV 62.69
- Support Level
- CRDF $2.06
- CBFV $33.28
- Resistance Level
- CRDF $2.33
- CBFV $34.50
- Average True Range (ATR)
- CRDF 0.11
- CBFV 0.60
- MACD
- CRDF -0.01
- CBFV 0.20
- Stochastic Oscillator
- CRDF 25.00
- CBFV 82.19
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.